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 Development of breast anthropomorphic phantoms 
for combined PET-Ultrasound elastography imaging 
 
Jun Dang, Philippe Lasaygues, Dachun Zhang, Stefaan Tavernier, Nicoas Felix,  Benjamin Frish, Serge Mensah and 
Mingxi Wan 
Abstract–A phantom has been developed for PET/US breast 
imaging. The phantom reproduces the acoustic and elastic 
characteristics of human breast tissue, and the different tissues in 
the phantom can be labeled with 18F FDG. The phantom was 
imaged with whole body PET/CT and also with Shear 
WaveElastography with  Supersonic Imagine Aixplorer system. 
We also test the phantom for other elastography methods such as 
static elastography. A 6D magnetic positioning system is used for 
image / volume matching and fusion. This phantom is developed 
for ClearPEM/US multimodal breast imager. 
I. INTRODUCTION 
reast cancer is the 2nd most common type of cancer [1] 
and the 5th most common cause of cancer death[2]. Breast 
cancer detection by X-ray mammography and by B-mode 
ultrasound scanning are in routine clinical use. X-ray 
mammography has a high sensitivity of about 90% for the 
detection of breast cancer [3], but its specificity for 
distinguishing malignant from benign lesions is only about 
20~50% (i.e., there are many false positives) [4]. Thus, a large 
fraction (> 50%) of the suspicious structures identified in 
mammograms are non-cancerous [5], and further diagnosis is 
necessary before deciding to treat the patient for cancer. The 
sensitivity and specificity of PET for detecting breast cancer 
are reported to be 92%~97% and 78%~90% [6], which is ideal 
for malignant tumor detection. On the other hand, ultrasound 
(US) has a diagnostic sensitivity 86%~100% and specificity 
80%~100%[7], and has excellent spatial and contrast 
resolution. It provides anatomical and even functional 
information (with US contrast agents). In addition US real 
time imaging is a non-radiating and low-cost technique. This 
motivates the Crystal Clear Collaboration to undertake the 
development of a combined breast PET/US scanner 
(CLEARPEM Sonic System). US elastography imaging, in 
addition to morphological information provided by US B-
mode imaging, provides the tissues’ elasticity distribution.  
Application of this technology to breast imaging has been 
reported to with promising results [8]. This motivates us to 
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also consider the combination of PET with US elastography. 
In this way it will not only be possible to obtain the functional 
and morphological information, but also the tissue elasticity 
distribution of the breast.  
An anthropomorphic breast gelatin-agar phantom has been 
developed as part of this project. Acoustical and elasticity 
characteristics of the phantom will be reported, as well as the 
results obtained with this phantom on commercial scanners.  
II. MATERIALS AND METHOD FOR PHANTOM PREPARATION 
We choose (GELITA EUROPE, Ballistic 2, photographic 
grade) and "high gel Agar"(SIGMA-ALDRICH Co.) to 
prepare the phantom. We measured the propagation speed of 
the acoustic waves, the attenuation coefficient and the 
elasticity (Young’s modulus) for several series of samples. 
We evaluated samples with gelatin mass percentages from 
1% to 15% and with agar mass percentages from 0.5% to 5%. 
This allowed us to find ingredients ratios that give samples 
with acoustic and elastic signature close to fat tissue, normal 
glandular tissue, fibrous/hard tissue and carcinoma in the 
breast. 
The acoustical propagation velocity and the attenuation 
coefficient of several series of samples were measured using 
transmission and time of flight techniques using 2 parallel 
single US transducers immersed in a water tank. We found 
that the gelatin% fraction in the sample will mainly affects 
acoustical velocity of the sample and that the agar% fraction 
has a bigger effect on the attenuation coefficient of the sample. 
 
    Gelatin % Agar % Mean velocity (m/s) Real tissue value(m/s) 
    1~5 0.5~10 1503 8 ~ 1507 4 1479±32 (fat) 
10 2~ 7 1526 7 ~15311 1553±35 (glandular tissue) 
 
15 1.5~7 15404 ~154311 1584±27(fibrous tissue) 
18 2~ 7 1550 7~1559 9 1550±35 (carcinoma) 
Agar% Gelatin% Mean 
Att(db/MHz/mm)  
Real tissue value(db/MHz/mm) 
0.5~2 1 ~18 0.050.02~0.080.06 0.05(fat) 
5 5~ 16 0.090.01~0.150.01 0.14(tissue) 
7 10 ~ 18 0.250.03 ~ 0.300.10 0.3(carcinoma) 
TABLE I.  PHANTOM ACOUSTIC CHARACTERISTICS 
From Table I top 5 rows, we find that as gelatin% increase, 
the average sound velocity also increases and they can be used 
to mimic breast fat, glandular tissue, fibrous tissue and 
B 
 carcinoma. While for the 6
th
 to 9
th
 rows it shows the average 
acoustic attenuation coefficient increases with Agar%. The 
phantom can mimic breast tissues both on velocity  and  side 
characteristics. 
Once, acoustical characterization was performed the 
samples elasticity was measured using NEED REFERENCE 
OF THE TECHNIQUE USED TO MEASURE 
ELASTICITY). We also tried to find a elasticity 
correspondence between the phantom and real breast tissue. 
(Need a reference of proven elasticity of breast tissues) 
 TABLE II.  PHANTOM ELASTICITY CHARACTERISTICS 
 
Table II shows the elasticity measurement results of the 
samples, which could mimic real breast tissues from acoustic 
point of view. The 2
nd
 column shows what kind of breast 
tissue they can mimic by acoustical requirements. The last 
column shows what kind of breast tissue they can mimic by 
elasticity requirements. The phantom can mimic breast fat 
medium and carcinoma both by acoustical and elasticity 
requirements.  
Based on these studies we were able to produce a realistic 
phantom simulating a human breast with a tumor.  
The steps in the production of the phantom are listed below: 
First, measure 1% gelatin and 0.5% agar and mix them with 
the correct amount of water, heat the beaker in a microwave 
oven until the water will just boil. This is for thepreparation of 
the fat medium type background. Put the beaker at room 
temperature and measure its temperature until it become 40⁰C. 
Add F
18-
FDG into the liquid gel and control the FDG activity 
4MBq/ml.  
Second, prepare inclusions with tumor type medium. 
Measure 12% gelatin and 4% agar, and mix them with correct 
amount of water. Heat them in microwave oven just before it 
boils. Stir the medium averagely and let it cool down to 45⁰C. 
Add F
18-
FDG in with activity 4 times higher than fat medium, 
which is 16 MBq/ml. Fill the inclusions into several figure 
latex hats (don’t understand what is a figure latex hat?) and 
sealed the hats tightly. Put the “inclusion balls” into fridge 
until they became solid.  
Third, remove the inclusion latex skin and emerge them 
softly into the liquid fat medium when the temperature of fat 
medium is 40⁰C. 
Fourth, wait for the whole phantom to became totally solid 
and make a PET scan of it.  
Without any care, the phantom will degrade within days 
after its production. We found that adding Germall-plus [9] as 
a conservation agent, greatly improved the conservation of the 
sample. In this way will keep several weeks in a normal 
fridge.  
After the PEM scan, a US scan can be performed 
immediately or several days later. 
III. IMAGING RESULTS 
The PET images of the phantoms were obtained with a 
PHILIPS GEMINI TF 64. For US imaging, as there are 
several different ways to generate US elastography, we have 
studied both static elastography by using DP-9900 
(Mindray,P.R.China) and Shear Wave Elastography using 
SuperSonic Imagine Aixplorer system with both 1D and 3D 
probes (SuperSonic Imagine, Aix en Provence, France) .  
A cubic shaped phantom was first prepared to study static 
elastography and a breast shaped phantom had been prepared 
later for shear wave elastography.  
For static elastography, a linear US probe with center 
frequency of 7.5 MHz and sampling frequency of 25MHz is 
used. A rectangular compressor with a polyethylene plate(size 
88mm*66mm) is used to enlarge the US probe contact surface 
between the phantom surface. US probe was fitted inside the 
compressor by a slot cut. US radio-frequency (RF) data were 
acquired by a 32 bit data I/O card. Both pre- and post-
compression US RF data were acquired. A US probe 
compression amount of 0.5mm was  applied. The strain 
imaging was based on the RF data from pre-compression and 
the post-compression. Local tissue displacements were 
estimated with 1D cross-correlation techniques by comparing 
the gated pre- and post-compression radiofrequency (RF) 
signals [10]. For all the elastograms, the length of the 
correlation window was fixed at 2.5mm, and a overlap 
window of 80% was used. To remove the signal deformation 
due to mechanical compression, temporal stretching [11] is 
conducted on post-compression signals with a stretching factor 
of the mean strain. After the displacement data were obtained, 
the axial strain was then computed from the displacement 
estimates using a third-order optimum low-pass differentiator 
[12]. The dynamic range (DR) of the static elastogram was set 
to 0~ 1.5%. 
SuperSonic Imagine uses a patented concept to introduce 
the shear wave into the body : ultrasound beams are 
successively focalized and sent into  different depths of tissue 
creating a shear wave in the medium. Using ultrafast imaging, 
the speed of the propagation of the shear wave at every point 
in the image is measured, and quantitative elasticity map can 
be deducted in kilo Pascal (kPa).The end result is a real-time, 
quantifiable, user-independent and reproducible ShearWave™ 
Elastography information. The technique is totally safe for the 
patient and respects all acoustic standards defined by the FDA 
and CE mark. First, we show results from PET and US static 
elastography. Phantom cross section images from PET and 
static elastography are listed below. B-mode image tells the 
anatomical structure, static elastography shows the Strain 
Gelatin & agar 
combination 
Acoustical 
tissue type 
Measured 
Young’s 
modulus(kPa) 
Real 
tissue 
value 
(kPa) 
Elasticity 
tissue type 
1% gelatin +0.5% 
agar 
Fat tissue 22  2 19±7 Fat tissue 
2%gelatin+1%agar Fat tissue 36  2     _ Fat/glandular 
tissue 
5% gelatin +2% agar Fat/Glandular 
tissue 
33  1 33±11 Glandular 
tissue 
12% gelatin +4% 
agar 
Glandular 
tissue 
73  9     _ Cancer  
15% gelatin +5% 
agar 
Carcinoma 117  8 99±33 Cancer/fibrous 
tissue 
 (elasticity) distribution, and PET image shows functional 
information. 
 
  
 
Fig. 1. Cross section phantom images show the US B-mode image, static 
elastography and whole body PET image. The white box in the whole body 
image tells the US probe scan region.  
 
Below is displayed the superimposed PET/B-mode/Static 
Elastography results. 
 
  
 
 
Fig. 2.  Comparison of  PET/US B-mode/US static elastography results. 
1st  top left  image shows PET/ US B-mode superimposed result. 2nd  top 
right image shows PET/US Static Elastogram superimposed result, 3rd 
bottom left image shows PET/ US B-mode /US static elastography  
synthesis superimposed results and the 4th  shows US B-mode/US static 
elastogram superimposed result. In the 4th  image, red color stands for strain 
distribution, it tells the fat tissue mimicking part. 
 
Compared with US B-mode imaging, US elastography shows 
a better ability to identify tissue differences. For inclusions 
whose acoustic characteristics is similar with the normal 
tissue around it (iso-echoic), US B-mode imaging can’t show 
a clear interface between the inclusion and normal 
background part but static elastography still can distinguish 
them effectively from their elasticity differences(Fig. 3). 
 Second we display phantom imaging results from 
SuperSonic shearwave elastography. As SuperSonic shear 
wave elastography  provides truly quantitative elastography 
that allows the physician independence from compressional 
movements inherent in conventional elastography. Fig. 4. 
shows the image fusion between whole body PET image and 
shear wave elastography.  
 
 
 
US probe 
scan 
region 
  
     Fig. 3.   When inclusion acoustical characteristics is similar between 
inclusion and background, US B-mode imaging can’t distinguish inclusion 
clearly but static elastography can still show the inclusion from background. 
White arrows labeled the same inclusion in B-mode image, elastography and 
PET image.  
 
     Fig. 4. Image fusion result of US B-mode / shear wave elastography/whole 
body PET images. This showed triple information of : tissue anatomical 
information, tissue  elasticity information and tissue functional information 
IV. IMAGE FUSION BY POSITIONING SYSTEM 
As the final purpose for the combination of ClearPEM and 
SuperSonic shear wave elastography system is to superimpose 
PET volumes together with US volumes, a 6D magnetic 
positioning system has been applied to assess the 3D volume 
registration. The spatial accuracy of the positioning system is 
1 mm and 0.1 degree ..We first make a breast shaped cone for 
phantom preparation and added 3 fiducial markers on the cone 
wall. This is used for registering PET volume. If we scan the 
phantom by a whole body PET/CT, the fiducial markers can 
be scanned by the CT scanner, so we can use the image 
correspondence to choose the needed PET image by CT 
fiducial marked images. We used the positioning system to 
record the positions of the fiducial markers together with the 
3D US probe, including the special angle of the US probe. 
With these positions data we can know compared with PET 
image, where should the US image be superimposed. Note that 
there is a window on the breast phantom cone for US probe 
scanning. Although the phantom will have a small 
deformation by US probe compression, only linear 
transformation is performed. With SuperSonic system both B-
mode volume and elastography volume are simultaneously. 
Fig. 5. shows the fiducial markers and positioning sensors. 
And image fusion results are shown in Fig. 6. The result 
shows an acceptable matching that demonstrates that  the 6D 
positioning system is working properly for PET/US volume 
matching and registration. 
 
 
  
Fig. 5. Fiducial markers and positioning system for image matching 
 
 
Fig. 6. Whole body PET image and Fused PET/US image. This shows the 
6D positioning system works for the image matching case. 
V. DISCUSSION AND CONCLUSION  
This gelatin-agar PET/US phantom is developed for 
combination research of a breast PET(ClearPEM) and  
commercialized US-elastography Aixplorer system 
(SuperSonic Imagine). The phantom has already been tested 
by whole body PET and it works well. With the excellent 
special resolution of ClearPEM( ≈ 1.5mm ), it is ideal to test 
the performance of ClearPEM with this phantom, e.g. we can 
prepare tumor type inclusions with different sizes(1mm, 2mm, 
3mm, etc.) to mimic the very realistic cases to demonstrate the 
performances of the ClearPEM system. With this phantom it is 
also possible to make a benchmarking evaluation between the 
performance of a  commercially available PET/CT and the 
ClearPEM system. Once volumes are obtained from 
ClearPEM, the phantom can still be scanned by any US 
imaging system to get US images for PET/US image fusion 
study. We already found tumor like inclusion with  sizes 
around 1mm can be detected by SuperSonic shear wave 
elastography system. The in-vitro performance test of 
ClearPEM system  should be performed in the future with this 
phantom. The PET/US dual modality system should be 
integrated together so that simultaneous volumetric imaging 
could be performed, and the phantom is an ideal training 
object for volume registration and system performance 
evaluation.  
For the ClearPEM scanning, the patient is laying with a 
prone position on the bed and the breast will be scanned 
between two parallel detector heads(Fig. 7). A mechanical arm 
will be used to hold the US probe between the two detector 
heads for simultaneous scanning (Fig. 8).  A breast shaped 
cone will be installed on the bed to fit the breast nature shape 
and different breast sizes (Fig. 9). There will also be a open 
US scan window on the breast cone wall to fit the US probe 
(Fig. 10).  
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                   Fig. 7                                                  Fig. 8 
     
                   Fig. 9                                                  Fig. 10 
 
For conclusion, we have developed a gelatin-agar dual 
modality phantom for PET/US breast imaging research. This 
phantom could mimic different breast tissues types such as fat 
tissue, glandular tissue, fibrous tissue and carcinoma. It works 
well for whole body PET/CT and for any US imaging system. 
Phantom should be used to test ClearPEM performance also.  
A 6D magnetic positioning system has been evaluated for 
PET/US volume registration and fusion. ,  Further test with 
ClearPEM system will be performed to optimize accuracy of  
this positioning system.    
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